THE life SCIENCE
Trusted medical news for healthcare professionals
Tuesday, 21 April 2026
Today on The Life Science Feed

Highlights

Newsletter
Sign up for one of our newsletters and stay ahead in Life Science
I have read and understood the Privacy Notice and would like to register on the site. *
I consent to receive promotional and marketing emails from The Life Science Feed. To find out how we process your personal information please see our Privacy Notice.
* Indicates mandatory field
News
General Practice|Croatia's Primary Care Reform What It Means for Your PracticeHaematology|Moving Beyond Deficiencies: Normalization Strategies in Hemophilia CareEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsCardiology|Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic ChallengePsychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisGastroenterology|Endoluminal Markers Predict Crohn's Treatment FailureCardiology|SSEPs to Monitor Cerebral Perfusion During TCAR TAVR ProceduresHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Endocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlEndocrinology|Metformin, Liraglutide, and Gut Microbiome Shifts in Youth-Onset T2DGeneral Practice|Croatia's Primary Care Reform What It Means for Your PracticeHaematology|Moving Beyond Deficiencies: Normalization Strategies in Hemophilia CareEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsCardiology|Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic ChallengePsychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisGastroenterology|Endoluminal Markers Predict Crohn's Treatment FailureCardiology|SSEPs to Monitor Cerebral Perfusion During TCAR TAVR ProceduresHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Endocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlEndocrinology|Metformin, Liraglutide, and Gut Microbiome Shifts in Youth-Onset T2D